🇺🇸 FDA
Patent

US 8481289

Triple acting antimicrobials that are refractory to resistance development

granted A61KA61K38/00A61K38/48

Quick answer

US patent 8481289 (Triple acting antimicrobials that are refractory to resistance development) held by The United States of America, as represented by the Secretary of Agriculture expires Mon Jul 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary of Agriculture
Grant date
Tue Jul 09 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K38/00, A61K38/48, A61K38/50